Evidence map›Paper›PMID 33828550›Full record

ArticleFrontiers in immunology2021

Immunophenotyping of Peripheral Blood Mononuclear Cells in Septic Shock Patients With High-Dimensional Flow Cytometry Analysis Reveals Two Subgroups With Differential Responses to Immunostimulant Drugs.

Ya Wang, Brian Gloss, Benjamin Tang, Suat Dervish, Brigitte Santner-Nanan, Christina Whitehead, Kristy Masters, Kristen Skarratt, Sally Teoh, Stephen Schibeci and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Observational
  5. Observational
  6. Article
  7. ANPELA: Significantly Enhanced Quantification Tool for Cytometry-Based Single-Cell Proteomics.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Ya WangDepartment of Intensive Care Medicine, Nepean Hospital, Penrith, NSW, Australia.
Brian GlossWestmead Research Hub, Westmead Institute for Medical Research, Sydney, NSW, Australia.
Benjamin TangDepartment of Intensive Care Medicine, Nepean Hospital, Penrith, NSW, Australia.
Suat DervishWestmead Cytometry, The Westmead Institute for Medical Research, Sydney, NSW, Australia.
Brigitte Santner-NananCharles Perkins Centre Nepean, Sydney Medical School Nepean, The University of Sydney, Kingswood, NSW, Australia.
Christina WhiteheadDepartment of Intensive Care Medicine, Nepean Hospital, Penrith, NSW, Australia.
Kristy MastersDepartment of Intensive Care Medicine, Nepean Hospital, Penrith, NSW, Australia.
Kristen SkarrattDepartment of Medicine, Faculty of Medicine and Health, Nepean Clinical School, The University of Sydney, Kingswood, NSW, Australia.
Sally TeohDepartment of Intensive Care Medicine, Nepean Hospital, Penrith, NSW, Australia.
Stephen SchibeciCentre for Immunology and Allergy Research, The Westmead Institute for Medical Research, Sydney, NSW, Australia.
Nicole FewingsWestmead Clinical School, University of Sydney, Sydney, NSW, Australia.
Chrystelle BrignoneImmutep S.A.S., Parc Club Orsay, Orsay, France.
Frederic TriebelImmutep S.A.S., Parc Club Orsay, Orsay, France.
David BoothCentre for Immunology and Allergy Research, The Westmead Institute for Medical Research, Sydney, NSW, Australia.
Anthony McLeanDepartment of Intensive Care Medicine, Nepean Hospital, Penrith, NSW, Australia.
Marek NalosDepartment of Intensive Care Medicine, Nepean Hospital, Penrith, NSW, Australia.
Westmead Institute for Medical Research · AUNepean Hospital · AUUniversity of Sydney · AUCharles University · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sepsis is associated with a dysregulated inflammatory response to infection. Despite the activation of inflammation, an immune suppression is often observed, predisposing patients to secondary infections. Therapies directed at restoration of immunity may be considered but should be guided by the immune status of the patients. In this paper, we described the use of a high-dimensional flow cytometry (HDCyto) panel to assess the immunophenotype of patients with sepsis. We then isolated peripheral blood mononuclear cells (PBMCs) from patients with septic shock and mimicked a secondary infection by stimulating PBMCs for 4 h

Indexed as

Flow CytometryImmunophenotypingMonitoring, ImmunologicAntigens, CDBiomarkersCase-Control StudiesCells, CulturedCytokinesHLA-DR AntigensHumansInterferon-gammaLeukocytes, MononuclearLipopolysaccharidesLymphocyte Activation Gene 3 ProteinPhenotypePredictive Value of TestsAntigens, CDBiomarkersCytokinesHLA-DR AntigensIFNG protein, humanInterferon-gammaLag3 protein, humanLipopolysaccharidesLymphocyte Activation Gene 3 Proteinsoluble LAG-3 protein, humanhigh-dimensional flow cytometryimmunophenotypeinterferon-γLAG-3IgLipopolysaccharidessepsis

Identifiers

PMID33828550
PMCPMC8019919
OpenAlexW3136063996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.